How public money goes into drug development
related content
EU: Don’t limit Indonesian access to medicine
In this letter, SOMO – together with a group of NGOs – urge the European Commission to drop provisions that protect intellectual property in the economic agreement (CEPA) between Indonesia-EU. They fear that the so…
SOMO report on Moderna incites change
SOMO’s recommendation for HERA – the new European centre for cross-border health threats
SOMO, together with a broad coalition, have sent a letter to health attachés and to the Health Commissioner of the European Union urging them to reconsider crucial aspects of the recently launched Health Emergency Preparedness…
Recommendations on ODA eligibility of spending related to Covid-19 vaccines
As some Development Assistance Committee (DAC) donors are considering using their Official Development Aid (ODA) budgets to cover expenditures related to Covid-19 vaccines, the work of the DAC is critical to ensure that ODA eligibility…
Moderna vaccine profits channelled to tax havens
Vaccine manufacturer Moderna is employing tax avoidance structures to shift its profits to Switzerland and the US state of Delaware, research by SOMO in cooperation with Wemos. The European Union ordered $10.3 billion worth of…
Moderna’s free ride
Pocketing tax free profits from publicly funded jabs
Conditions placed on public funding of corona vaccines are hollow
Conditions attached to Dutch government investments in corona vaccines and medication to guarantee affordability and accessibility are are insufficient at best and, at worst, counterproductive. Vaccine manufacturing companies are able to negotiate conditions into the…
How can we make publicly funded corona vaccines accessible to all?
Two election debates
SOMO is co-organising two debates (in Dutch) in the run-up to the Dutch elections on 17 March. Het Grote Buitenlanddebat – 24 February During the “Grote Buitenlanddebat”, candidate MPs will debate the role of the…
Global vaccine scarcity unnecessary if pharma shares knowledge
In a joint letter, SOMO together with 53 civil society organisations are calling upon the Dutch government to ensure that pharmaceutical companies share their knowledge of vaccine development with other companies in an existing pool…